Reported about 10 hours ago
Johnson & Johnson reported better-than-expected first-quarter earnings but is facing concerns over an expected $400 million impact from tariffs, predominantly from China affecting its medical device business. CFO Joe Wolk highlighted that these tariffs stem from products not exempt under the USMCA, with a significant portion coming from retaliatory tariffs imposed by China.
Source: YAHOO